Caricamento...

Progression of mild Alzheimer’s disease: knowledge and prediction models required for future treatment strategies

INTRODUCTION: Knowledge of longitudinal progression in mild Alzheimer’s disease (AD) is required for the evaluation of disease-modifying therapies. Our aim was to observe the effects of long-term cholinesterase inhibitor (ChEI) therapy in mild AD patients in a routine clinical setting. METHODS: This...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Wattmo, Carina, Wallin, Åsa K, Minthon, Lennart
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2013
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3978889/
https://ncbi.nlm.nih.gov/pubmed/24099236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt210
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !